Introduction
============

Epilepsy is a common neurological disease characterized by the manifestation of unprovoked seizures ([@B42]). An epileptic seizure is "a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain" ([@B43]). Seizures are represented by a stereotypic sequence of electroencephalographic events and associated clinical symptoms. Seizure termination can be described as a homeostatic self-limitation of the hypersynchronous activity, representing not a mere cessation but a characteristic change in the excitability of the nervous tissue. These changes evolve successively and may already start during the course of the seizure before the activity would terminate ([@B33]). The current review focus on the contribution of altered energy metabolism to seizure control. For reviews on other anticonvulsant mechanisms mediated by intrinsic ion-channel modifications, changes in functional, network and synaptic properties of the neurons and effects of neuromodulators see [@B102] and [@B182].

Seizures represent an extraordinary burden on the energy metabolism of the brain as restoration of the transmembrane ion gradients is mediated by energy consuming pump mechanisms. Thus, it is tempting to speculate that the metabolic changes that develop slowly during the course of a seizure might finally lead to the cessation of the hypersynchronous activity. Metabolic alterations may include altered substrate and oxygen availability, accumulation of metabolic intermediates and byproducts (such as adenosine, lactate and CO~2~) which in turn leads to activation of adenosine receptors, extracellular acidosis and opening of K~ATP~ channels due to local shortage of ATP. These changes build up consecutively during the course of a seizure establishing conditions that not only contribute to the cessation of the activity but could potentially alter the normal neuronal functioning in the postictal phase. Conversely, disturbed energy metabolism could by itself favor seizure initiation by altering the ability of the tissue to recover transmembrane ion gradients following neuronal activity, as it is seen in mitochondrial encephalopathies ([@B75]; [@B181]) or in mesial temporal lobe epilepsy ([@B138]; [@B13]). Interictal hypoperfusion ([@B57]; [@B157]; [@B53]) and hypometabolism ([@B67]; [@B20]; [@B69]) have been demonstrated in a wide range of epileptic syndromes including temporal lobe epilepsy, generalized childhood absence epilepsy and status epilepticus. Although seizure-induced cell loss and sclerotic modification of the tissue could partially explain the hypometabolic state, there is also evidence for dysfunction of the neurometabolic coupling ([@B77]) and oxidative damage of respiratory enzymes ([@B93]; [@B169]; [@B45]; [@B138]). Lasting deficiencies in energy metabolism might underlie the frequent observation that "seizures-beget-seizures" ([@B9]; [@B37]) by favoring the initiation of subsequent hypersynchronous activity ([@B181]). Mismatch in the neurometabolic coupling might be responsible for seizure-associated cell loss via either free radical dependent or hypoxic mechanisms ([@B73]; [@B48]; [@B91]; [@B138]). Metabolic disturbances might also contribute to the development of pharmacoresistance, i.e., the incapability to prevent seizures with two or more antiepileptic therapy regimens directly or indirectly following sclerotic transformation of the tissue ([@B87]). Thus, it is fundamental to understand the potentially pro- or anticonvulsant consequences of the seizure-associated changes in energy metabolism.

In the following we provide a short overview of the literature about the alterations of neurometabolic coupling during seizures and how these could contribute to seizure control. We discuss possible therapeutic targets which exploit metabolism-related mechanisms (2-deoxy-[D]{.smallcaps}-glucose (2DG), pyruvate, fructose 1,6 bisphosphate, ketogenic diet, CO~2~ inhalation, carbonic anhydrase inhibitors, adenosine 1 agonists). The last part is devoted to the mechanisms of seizure-induced neurovascular decoupling, which might be responsible for postictal hypometabolism and have been suggested to be associated with cognitive disturbances. We apologize that we cannot extensively discuss all aspects of seizure termination and regulation of neuronal energy metabolism as well as the anti-seizure mechanisms associated to caloric restriction and ketogenic diet.

Neurometabolic Coupling During Acute Seizures and in Chronic Epileptic Tissue
=============================================================================

Neuronal activity results in local changes in transmembrane ion-gradients, such as the increase in extracellular \[K^+^\] which is immediately countered by a concurrent increase in Na-K-ATPase activity ([@B104]). In order to keep pace with the ATP-demand of the ion-pump activity as well as that of the transport processes related to synaptic signaling ([@B101]; [@B59]), energy metabolism has to adopt to the different neuronal activity states ([@B2]; [@B65]; [@B12]). This neurometabolic coupling could operate via "pull" and "push" mechanisms, i.e., either as a consequence of alterations in ATP or other energy metabolism intermediates, or in a feed forward manner by activity dependent changes in intracellular and intramitochondrial Ca^2+^, K^+^ and nitric oxide (NO) concentrations ([@B158]; [@B23]). During physiological and interictal activity, changes in overall intracellular ATP concentration are expected to be rather small (see Seizure Associated Alterations in Energy Metabolism Intermediates and pH). Yet, an increase in ATP utilization by the Na-K-ATPase leads to a concomitant increase in ADP and AMP concentration, as the adenylate kinase maintains a fast equilibrium between the adenine nucleotides. Assuming an ATP level of 3mM and an ADP level of 0.3 mM, even a minor decrease in ATP by 10% would decrease the ATP/ADP ratio from 10 to 4.5 and increase AMP levels more than fourfold. These changes in adenylates have immediate consequences for the regulation of energy metabolism (**Figure [1](#F1){ref-type="fig"}**). First, the adenine nucleotide translocator is activated leading to a decrease in mitochondrial ATP and mitochondrial membrane potential (ψ) as the exchange of ATP (3 negative charges) for ADP (2 negative charges) is an electrogenic process. The shift in cytosolic and mitochondrial ATP/ADP ratio and the decrease in ψ activate F0F1-ATPase, further draining the ψ. As a consequence, complexes IV, III, and I of the ETC are activated by associated shifts in the electron carriers, cytochrome C and ubiquinone (QH~2~). This activation results in the initial oxidation shift in mitochondrial NADH, which can be observed by NADH-autofluorescence ([@B92]; [@B149]; [@B12]). The decrease in mitochondrial NADH activates the regulatory dehydrogenases of the tricarboxylic acid cycle as well as the pyruvate dehydrogenase reaction, thereby channeling pyruvate into the tricarboxylic acid cycle. At the same time, the glycolytic pathway is activated by the decreased ATP/ADP ratio and the increase in AMP at the glucokinase, phosphofructokinase and pyruvate kinase level, providing the pyruvate needed for increased aerobic metabolism. Normally, the increase in glycolytic activity exceeds the increase in aerobic metabolism and the excess pyruvate is exported in the form of lactate ([@B12]).

![Schematic representation of central neuronal energy metabolism (adapted from [@B8]). Proton dependent processes are presented in magenta and calcium dependent processes are presented in blue. Glycolysis degrades glucose beginning with hexokinase (hk) dependent phosphorylation to glucose-6-phosphate ending with pyruvate kinase (pk) dependent formation of pyruvate. Pyruvate can by either transformed to lactate by the lactate dehydrogenase (LDH) and be exported from the cell by monocarboxylate transporter (MCT) (anaerobic glycolysis) or taken up into the mitochondria via proton symport by pyruvate transporter (PyrT) with subsequent conversion to Acetyl-Coa by pyruvate dehydrogenase (PDH) for oxidation to CO~2~ in the citric acid cycle (CAC) (aerobic glycolysis). The CAC cycle, starting with the formation of citrate (Cit) from oxaloacetate (OA) and acetyl-CoA (ACoA) by citrate synthase (CS) and proceeding via the formation of isocitrate (IsoCit) by aconitase (ACN), α-ketoglutarate (aKG) by isocitrate dehydrogenase (IDH), succinyl-CoA (SucCoA) by α-ketoglutarate dehydrogenase, succinate (Suc) by succinyl-coA synthetase, fumarate (Fum) by succinyldehydrogenase, malate (Mal) by fumerase (FUMR) and the replenishing of OA by malate dehydrogenase (MDH), forms NADH and FADH2 used by the respiratory chain (RC). Complex I-IV of the RC are proton pumps generating the proton motive force that determine the rate of proton-assisted ion transport of Na+, K+, Ca2+ and phosphate (P) across the inner mitochondrial membrane, the rate of the adenine nucleotide transporter (ANT) exchanging mitochondrial ATP against cytosolic ADP and the rate of ATP synthesis by the F0F1-ATPase (F0F1). Shuttling of electrons (NAD-bound hydrogen) between the cytosol and the mitochondrial matrix is catalyzed by the Malate-Asparte shuttle, comprising the malate/α-ketoglutarate carrier (MAC), the mitochondrial and cytosolic aspartate amino transferase (AAT) and the proton driven antiport of glutamate (Glu) and aspartate (Asp) by the aspartate/glutamate carrier (AGC). Besides protons, calcium plays a key role in neuronal energy metabolism as it controls the key mitochondrial dehydrogenase PDH, IDH and KGDH and the rate of electron shuttling by AGC (ARALAR). Calcium uptake into the mitochondrion proceeds in a calcium dependent manner by MCU thereby coupling neuronal excitation with neuronal energy metabolism.](fncel-12-00335-g001){#F1}

The "push" mechanisms, such as the mitochondrial Ca^2+^-cycle, are complementary in regulating energy metabolism ([@B88]; [@B170]; [@B12]; [@B119]; [@B78]). Neuronal firing and synaptic activity results in localized transient cytoplasmic Ca^2+^ increases, which are sequestered by mitochondria via the mitochondrial Ca^2+^ uniporter (MCU) channel complex leading to increased matrix Ca^2+^ concentration. Matrix Ca^2+^ plays a key regulatory role as it can enhance ETC in a potassium dependent manner ([@B158]), increase aspartate malate shuttle and pyruvate supply ([@B52]; [@B139]) and it is a positive modulator of three key dehydrogenases of the tricarboxylic acid cycle (TCA, [@B107]; [@B23]), thereby leading to the enhanced formation of reducing equivalents (**Figure [1](#F1){ref-type="fig"}**). Typical biphasic changes in the redox state of flavin and adenine dinucleotides (FADH~2~ and NADH) can be observed following physiological stimulus *in vivo* ([@B79]) and during seizure-like events in brain slices consisting of an initial oxidation and a lasting reduction which outlasts the hypersynchronous activity ([@B148]; [@B92]). In this latter preparation enhanced Ca^2+^ cycling across the mitochondrial membrane during seizures has been shown to be responsible for the dissipation of ψ ([@B88]), although the contribution of the mitochondrial permeability transition induced by high mitochondrial Ca^2+^-load cannot be completely excluded ([@B86]). While mitochondrial depolarization by definition decreases the proton motive force (composed of Δψ and ΔpH ), it could also represent one way to enhance respiration ([@B106]). Due to the fixed stoichiometry of the F0F1-ATPase of three protons per generation of one ATP, the decrease in proton motive force will have no energetic efficiency consequences as long as the energy of the three protons exceed the formation enthalpy of ATP. However, the ψ dependence of the F0F1-ATPase activity leads to a strong activation and thereby increased ATP formation (see above). Thus, seizure termination *in vitro* seems to occur in the presence of enhanced energy metabolism, when neither the availability of the reducing equivalents nor oxygen could represent a limitation for the electrical activity ([@B145]). However, in case of frequently recurring seizure-like events, which would resemble status epilepticus *in vivo*, signs of metabolic impairment develop in a free radical dependent manner ([@B91]; [@B106]; [@B181]). Under these conditions seizure termination is impaired and the electrical activity transforms from seizure-like events to pharmacoresistant late recurrent discharges, indicating that the slowly developing energy crisis is rather pro-epileptic ([@B148]; [@B74]). Seizure-associated enhancement of mitochondrial free radical formation might play an important role in the development of metabolic disturbances both *in vitro* ([@B48]; [@B91]) and *in vivo* ([@B93]; [@B169]; [@B138]). In addition, the seizure associated increase in NO formation was found primarily pro-epileptic as blockade of the neuronal NO synthase decreased severity of kainic acid induced seizures *in vivo* ([@B7]) and delayed seizure onset *in vitro* ([@B147]; [@B90]). Unfortunately, it is not possible to unequivocally determine the contribution of NO-mediated inhibition of the electron transport chain complexes to the pro-epileptogenic effect ([@B98]), as NO influences neuronal excitability and cerebral blood flow in many different ways.

Most of the aforementioned findings were obtained in experiments with acutely induced epileptiform activity in tissue samples of otherwise healthy animals. However, in chronic epileptic tissue the metabolic consequences of prior activity might influence the effects of seizures on energy metabolism. Indeed, signs of metabolic impairment were evident in sclerotic hippocampal tissue from epilepsy patients as well as in the pilocarpine model of epilepsy, which may correspond to the hypoperfusion and hypometabolism in these areas ([@B93]; [@B169]; [@B77]). In conclusion, although metabolism related factors (see below) might contribute to seizure termination, this can also happen in the presence of intact neurometabolic coupling and - at least *in vitro*- no obvious restriction of glucose and oxygen supply (**Figure [2](#F2){ref-type="fig"}**). On the other hand, metabolic disturbances during frequently recurring seizures or in chronic epileptic tissue rather favor than limit the occurrence of hypersynchronous activity ([@B121], and citations therein).

![Summary scheme of seizure-associated changes in cellular energy metabolism and cerebral blood. **(A)** Seizure-associated changes in transmembrane ion gradients ultimately activate neuronal energy metabolism in order to counterbalance the ATP-need of the ion pump activity. In brain slices kept under constant carbogen gassing conditions seizure-associated enhancement of respiration can be measured as a drop in pO~2~ whereas a shift in the fluorescence of NADH represents the metabolism-dependent redox shift of this electron carrier (fp: local field potential). Whereas the respiration slowly returns to the pre-seizure values following cessation of the activity, the reducing shift in the NADH/NAD^+^ ratio outlast the changes in respiration. This mismatch might favor the late enhancement of reactive oxygen species (ROS) formation, as represented here by the oxidation of the mitochondrially targeted ethidium derivative, MitoSox in the same preparation. Seizures are associated with reversible arteriolar and capillary vasodilation, the latter likely mediated by contractile pericytes, and a consequent overshooting pO~2~ response. **(B)** There are considerable differences in the seizure-associated neurometabolic and neurovascular responses between early and late events during status epilepticus, as well as in healthy and chronic epileptic tissue (arrows indicate the direction of the change of individual parameters). Seizure-associated overshooting NADH reduction eroded during recurrent seizures *in vitro* and it was almost absent in chronic epileptic tissue from epilepsy patients, due to the free radical dependent damage of mitochondrial dehydrogenases. On the other hand, mitochondrial injury might in turn enhance subsequent formation of reactive oxygen species (ROS) in a vicious cycle. Seizures resulted in lactate release both in control and chronic epileptic tissue samples, whereas in the latter even interictal lactate levels were increased likely reflecting altered expression pattern of monocarboxylate transporters and energy metabolism of glial cells. Seizure-associated enhancement of respiration and lactate release result in a metabolic acidosis, which -- along with the enhanced adenosine levels- represents a strong anticonvulsant mechanisms even in chronic epileptic tissue. Despite the induction of massive CBF increase by seizures vascular responsiveness was found to be decreased following status epilepticus, and changes in pericytic reactivity are observable already few minutes after seizure onset. This could be brought by oxidative stress of these cells as described in the no reflow phenomenon after hypoxia-reperfusion. Although seizure-associated increase in nitric oxide (NO) formation contributes to the hyperemia, in the presence of superoxide NO is turned into peroxynitrite with deleterious consequences on microcirculation. Postictal hyporesponsiveness of the microvasculature has been speculated to underlie cognitive disturbances and epilepsia comorbidities, whereas damage of the blood-brain barrier (BBB), albumin leakage and the subsequent transformation of the nervous tissue were shown to be pro- epileptogenic. (hippocampal pyramidal cell and capillary pericytes are just for illustration purposes, some of the traces in A are adopted from [@B106]).](fncel-12-00335-g002){#F2}

Seizure Associated Alterations in Energy Metabolism Intermediates and pH
========================================================================

Recurrent seizures represent an extraordinary metabolic burden, leading to increased tissue lactate and decreased phosphocreatine, glucose and glycogen content ([@B44]). One plausible explanation for self-limitation of the hypersynchronous activity would be an exhaustion of the high energy phosphate and/or the glucose reserves. Neuronal metabolism is fueled almost exclusively by glucose as substrate, but the role of glucose availability in seizure development and termination is controversial. The glucose transporter GLUT1 plays an essential role in capillary to brain glucose transport and mutations in the SLC2A1 gene that encodes GLUT1 lead to deficiency of the transporter and cause several types of generalized epilepsy ([@B68]). Epilepsy patients with diagnosed GLUT1 deficiency highly benefit from ketogenic diet. Severe hypoglycaemia by itself is known to induce seizures and moderate hypoglycemia decreased the threshold of seizure induction by fluorothyl *in vivo* ([@B82]). This could be brought about by the enhanced excitability as a consequence of altered Na-K-ATPase activity. Alternatively, an imbalance of excitatory and inhibitory neuron tonus has been also suggested, as the latter cells are more dependent on oxidative metabolism ([@B134]). On the contrary, hypoglycaemia exerted anticonvulsant effects *in vitro* on low-Mg^2+^ induced seizures ([@B82]). With respect to another immediate energy resource, phosphocreatine, it was shown that brain-type creatine kinase deficient transgenic mice were less prone to develop seizures under pentylenetetrazole. In these animals initial discharges developed into a depression, which suggests that an energy crisis might actually contribute to seizure termination ([@B156]). However, the evidence for an energy crisis in terms of ATP depletion is rather limited in other animal models of epilepsy. ATP and high energy phosphate levels are kept close to normal even during recurrent seizures (status epilepticus) lasting for hours as was shown in an NMR study of kainate-induced status ([@B109]). By modeling seizure associated changes in energy metabolism intermediates and cerebral metabolic rate of oxygen consumption (CMRO~2~) in a brain slice preparation Schoknecht and colleges showed that a fivefold increase in CMRO~2~ was able to compensate for the enhanced energy demand of seizures whereas the decrease in overall cytosolic ATP content remained relatively small ([@B145]). Nevertheless, in certain metabolic compartments -- such as the axonal/presynaptic domain of fast spiking interneurons - larger local ATP consumption could be hypothesized ([@B70]).

In addition to the increased blood flow and the consequent increase in glucose supply, astrocytic glycogen reserves are also mobilized during seizures ([@B44]). Astrocytes form an electrically and metabolically coupled network of cells ([@B13]), which is capable to transport glucose to the most active areas during seizure-like events *in vitro* ([@B137]). Impairment of gap junctional coupling and connexin expression of astrocytes is often observed in chronic epileptic tissue ([@B8]). Whether these changes contribute to the control of seizures remains controversial as both, pro- and anticonvulsant effects of the uncoupled network are possible, via impaired potassium, glutamate buffering and nutrient redistribution, respectively ([@B13]; and citations therein).

In addition to enhanced oxidative metabolism, surplus glucose can be turned into lactate by anaerob metabolism. Interstitial lactate accumulation during seizures is a general finding in patients, animals as well as in *in vitro* models of epilepsy ([@B16]; [@B109]; [@B26]). In epilepsy patients interictal lactate levels were found to be elevated, suggesting altered energy metabolism and lactate turnover in general ([@B19]). Although lactate is effectively removed into the bloodstream, it has been long speculated that lactate might serve as an alternative substrate for energy metabolism of neurons under conditions of increased demand. Despite the controversy on the validity of astrocytic-neuronal lactate shuttle (ANLS) ([@B125]; [@B25]), lactate seems to play a role in synaptic transmission and plasticity in the presence of ample glucose and might support energy demanding network oscillations in the gamma range ([@B50]; [@B118]). Monocarboxylate transporters (MCT) mediate lactate uptake and release, depending on the transporter affinity and the concentration gradients, although lactate release via ion channels has been also described ([@B129]; [@B153]). MCT4 is the major MCT isoform present with particularly high density at the astrocytic endfeet enwrapping the cerebral microvasculature ([@B129]), hinting that MCT4 facilitates the removal of lactate into the circulation. In addition to the perivascular endfeet, the high affinity MCT2 isoform is preferentially localized on post-synaptic structures ([@B11]; [@B10]) suggesting that this isoform might be responsible for the metabolic support of synaptic signaling ([@B49]; [@B118]). The low affinity isoform MCT1 is expressed in astrocytes, oligodendrocytes and capillary endothelial cells and it is critically involved in oligodendrocyte development and maintenance of axonal functions ([@B99]).

We have recently shown that intrinsic lactate supports synaptic signaling in rat hippocampal slices and it contributes to energy demand of the restoration of transmembrane ion gradients ([@B3]). Inhibition of the MCT2-mediated lactate transport by α-cyano-4-hydroxycinammic acid (4CIN) led to a decrease in postsynaptic action potential generation and this effect was dependent on the activation of K~ATP~ channels, indicative of local energy shortage. Indeed, MCT inhibition reduced basal and stimulus-dependent CMRO~2~ and induced marked alterations in the redox state of mitochondrial FADH~2~ ([@B3]). With respect to hypersynchronous activity we found a strong inhibition of interictal- and seizure-like events in presence of 4CIN in different *in vitro* models of epilepsy. Interestingly, while K~ATP~ channels contributed to the suppression of synaptic activity, the anticonvulsant effect of MCT inhibitors could not be blocked by glibenclamide, which is in line with the assumption that seizure-associated overall increase in ATP consumption is counterbalanced by the enhanced oxidative metabolism ([@B145]). The anticonvulsant effect of MCT inhibitors was present both, in brain slices from control rats and also in chronic epileptic tissue from epilepsy surgery. This suggests that lactate support of energy metabolism during seizures is a general phenomenon and it is not affected by the observed changes in MCT expression in chronic epileptic tissue ([@B95]; [@B4]). The anticonvulsant effect of lactate uptake inhibitors complements the study of Sada and colleges, demonstrating that inhibition of the lactate dehydrogenase (LDH) with a stiripentol analog suppressed seizures in the pilocarpine model *in vivo* ([@B141]).

The suppression of seizure-like activity by MCT inhibitors was not mediated by extracellular lactate accumulation and subsequent acidosis but rather by activation of adenosine receptors following adenosine release upon enhanced neuronal activity in the presence of substrate restriction. Application of the adenosine 1 (A1) receptor antagonist DPCPX could reverse completely the antiseizure effect of 4CIN ([@B4]) indicating the critical role of these receptors in seizure termination. Indeed, endogenous adenosine is known to be released during seizures and A1 receptors are mainly responsible for the control of neuronal excitability by adenosine ([@B31]; [@B38]; [@B103]). Microdialysis studies in patients with temporal lobe epilepsy have also shown that adenosine levels rise as a consequence of seizures and the subsequent seizure termination is mediated by the activation of A1 receptors ([@B32]; [@B168]). A1 receptors are Gi/o protein coupled receptors which reduce the release of glutamate by inhibiting voltage-gated calcium channels ([@B94]; [@B113]) and decrease postsynaptic excitability of neurons by enhancing G-protein coupled inwardly rectifying potassium conductances ([@B58]; [@B165]). Adenosine is thought to act as a neuromodulator involved in the homeostatic balance between inhibition and excitation, whereby A1 receptors may be responsible for reduced excitability and synaptic transmission subsequently resulting in a dampened network activity ([@B22]; [@B24]). In fact, A1 receptors were found to decrease the power of gamma oscillations in hippocampal brain slices ([@B130]; [@B150]). Activation of A1 receptors has in general a strong anticonvulsant efficacy in both rodent and human brain slices ([@B159]; [@B84], [@B83]). A1 agonists were even capable to prevent the transition to status epilepticus-like recurrent discharges *in vitro* ([@B5]) suggesting that status epilepticus may result from impaired adenosine receptor-dependent seizure termination mechanisms ([@B176]; [@B85]; [@B61]).

Notably, inhibiting glycolysis by application of 2DG is able to arrest seizures in different *in vivo* models ([@B155], [@B154]; [@B151]). However, a more intricated set of effects is hinted by the findings that acute exposure to 2DG could either elevate or decrease the seizure threshold, depending on the epilepsy model (6 Hz stimulation versus kainic acid, PTZ, electroshock and amygdala kindling induced seizures; [@B51]), whereas chronic application of 2DG initiated epileptogenesis ([@B143]), likely mimicking the effect of mild hypoglycaemia. Thus, Gasior and colleges concluded that the proconvulsant action might be related to restriction of glucose uptake and subsequent hypoglycaemia while anticonvulsant effects could work via the inhibition of glycolysis. Under these conditions, glucose metabolism is shunted via the pentose phosphate cycle, which has been suggested to be anticonvulsant *per se* ([@B100]). Remarkably, in this study bypassing the block of the glycolytic pathway by the administration of extrinsic lactate abolished the anticonvulsant activity of 2DG in the pilocarpine model of epilepsy. This finding further reinforces the role of intrinsic lactate as possible energy resource during seizures and not a mere byproduct, which has to be removed into the bloodstream. Alterations in the expression pattern of different MCT subtypes in chronic epileptic tissue are in favor of lactate retention ([@B95]), which might explain the increased interictal lactate levels, despite of the hypometabolism ([@B19]).

The acute anticonvulsant effects of the ketogenic diet might be also related to the fact that ketone bodies represent a bypass of glycolysis, supporting the role of lactate in seizure control ([@B63]). However, mimicking the ketogenic diet *in vitro* failed to prevent the occurrence of seizures ([@B142]). On the long term both, chronic 2DG supply and ketogenic diet seem to work by changing gene expression and the whole machinery of energy metabolism ([@B14]). Similar long term changes might underlie the fact that chronic metabolic support by pyruvate administration can be actually anticonvulsant in three different epilepsy models ([@B133]). As these alterations are not expected to contribute to seizure termination under normal dietary conditions, the reader is referred to excellent recent reviews on this topic.

Although the effect of MCT inhibitors was not mediated by changes in pH, the acidosis occurring during seizures is in turn capable to reduce neuronal excitability ([@B104]; [@B173]; [@B171]) and by itself can exert strong anticonvulsant effects ([@B18]). Extracellular acidosis emerges from the enhanced respiration resulting in H~2~CO~3~ formation in addition to the release of lactate ([@B115]). Besides its intracellular effects ([@B170]) metabolic acidosis can alter excitability by many different ways ([@B152]), i.e., by activation of ASIC channels on interneurons ([@B179]) negative modulation of the *N*-methyl-[D]{.smallcaps}-aspartate (NMDA) receptor currents ([@B161]), inhibition of presynaptic voltage gated Ca^2+^ currents ([@B171]) as well as facilitation of ecto-ATPases and increasing adenosine release ([@B29]).

Nevertheless, intracellular acidosis could directly influence GABAergic transmission as the GABA receptor channel is permeable to HCO~3~^-^ ([@B124]; [@B140]). Indeed, inhibitors of brain carbonic anhydrases, which actively control pH balance by catalyzing the interconversion of carbon dioxide to bicarbonate (HCO3^-^) and a proton (H^+^), possess anticonvulsant effects ([@B136]; [@B112]).

Thus, while manipulation of substrate availability and metabolic pathways could be pro and anticonvulsive, acidosis and adenosine represent two powerful and interdependent negative feedback mechanisms for intrinsic seizure termination by signalizing excessive metabolic activity before shortage of the substrates would appear ([@B29]; [@B164]).

Seizure-Associated Changes in CMRO~2~ and Cerebral Blood Flow
=============================================================

Besides the potentially catastrophic events such as disturbances in cerebral blood flow or phenomena like spreading depolarization ([@B28]), seizures represent a metabolic burden which likely pushes brain energy metabolism to its limits. This assumption is supported by the finding that energy demanding physiological-type of network activity, such as carbachol induced lasting gamma oscillations in the brain slice preparation, result in a similar increase in CMRO~2~ as observed during seizure-like activity in the same tissue ([@B71]; [@B76]). While the enhancement of CMRO~2~ is sufficient to keep transmembrane ion-gradients constant during gamma oscillations, seizure-like events result in massive changes in ion homeostasis ([@B72]). Thus, it is tempting to speculate that ion transport capacity -and the corresponding ATP demand- is covered by the increase in the CMRO~2~ under physiological network activity. Any further increase in ion-fluxes exceeding pump capacity would result in altered transmembrane gradients, without further induction of CMRO~2~ increase.

Seizure-associated increases in CMRO~2~ *in vivo* can be calculated from the simultaneous determination of local tissue pO~2~ and cerebral blood flow (CBF, [@B54]; [@B162]) or by using fMRI as CBF, CMRO~2~ and CBV are the dominant physiologic parameters that modulate the BOLD signal ([@B80]). However, these calculations has to take into account the local variability of the signals and the fact that their relation can be changed by the seizure itself. Thus under bicuculline induced lasting ictal activity a positive BOLD was observed in the cortex and a negative BOLD signal in the hippocampus, despite of the increase in CBV and neuronal activity in both regions, suggesting a local mismatch between CMRO~2~ and CBF ([@B146]).

The brain slice preparation offers a simpler solution, because in the absence of blood flow, and permanent carbogen gassing (95%O~2~ 5%CO~2~) of the tissue, local pO~2~ depends solely on the rate of respiration and the diffusion distance from the surface ([@B101]; [@B72]). By recording basal and seizure-associated changes in pO~2~ and extracellular potassium/sodium concentration it was possible to calculate ATP consumption, ATP levels, CMRO~2~ and to predict the electron flow via the TCA enzymes and electron carrier nucleotides, FADH~2~ and NAD ([@B145]). The transformation from interictal to seizure-like events was associated with a fivefold increase in oxygen consumption, whereas the corresponding increase in ATP demand was significantly higher, indicating that coupling ratio (ATP/O~2~) and thereby the efficiency of oxidative metabolism is improved during seizure-like events. Notably, at maximum CMRO~2~, tissue pO~2~ as well as the reducing equivalents for the ETC were not rate limiting for the energy metabolism, suggesting that shortage of these factors is not a necessary prerequisite for seizure termination ([@B47]; [@B74]). Although these data were obtained *in vitro*, the results on CMRO~2~ and pO~2~ distribution can be extrapolated to the *in vivo* situation by knowing the intercapillary distance and the seizure-associated changes in local cerebral blood flow response.

In general, based on the close relationship between neuronal activity and vascular response (i.e., neurovascular coupling), seizures induce reversible vasodilation and disproportionally high increases in the blood flow, resulting in an overshooting supply of oxygenated hemoglobin, underlying the seizure-associated BOLD response ([@B166]; [@B163]). The first hypotheses of functional hyperemia assumed that increased energy consumption by active neurons induce vasodilation directly by altering the concentration of extracellular potassium, oxygen, protons and different metabolites ([@B120]). Alternatively, neuronal activity-dependent increase of extracellular glutamate can induce the release of vasoactive substances such as NO leading to subsequent smooth muscle cell relaxation ([@B96]; [@B15]). Astrocytes, the anatomical intermediaries between neurons and blood vessels, are important mediators of neurovascular coupling by releasing either vasodilator or vasoconstrictor agents in addition to potassium signaling at the astrocytic end-feet ([@B180]; [@B40]; [@B55]; [@B127]; [@B41]). Ictal increases in parenchymal lactate concentration also contribute to the regulation of cerebral blood flow. In the presence of restricted oxygen availability and high astrocytic calcium concentrations astrocytic lactate release is maximized. The subsequent lactate accumulation attenuates transporter-mediated uptake of prostaglandin E2 (PGE2) from the extracellular space leading to subsequent vasodilation ([@B55]). Thus, the vascular effect of lactate has to be kept in mind when considering the anticonvulsant effects of lactate uptake or glycolysis inhibitors under *in vivo* conditions. Finally, seizure-associated increases in extracellular adenosine have also vasodilatory effects by inhibiting constriction of arteriolar smooth muscle cells via adenosine receptors ([@B55]).

The overshooting blood flow response to seizures led to the 'unorthodox' hypothesis that ictogenesis is actually a restorative process to increase supply in underperfused areas ([@B27]). Nevertheless, more recent results show that BOLD signal is preceded by a local pO~2~ dip and temporary reduction of the blood flow was documented in the tissue surrounding the epileptic focus as well as in the contralateral hemisphere ([@B178]; [@B105]; [@B62]), indicating that the underperfusion *per se* is not an initiator of ictogenesis.

Status epilepticus and even a single seizure is associated with neuronal injury which in turn might favor secondary ictogenesis ([@B64]). The first clear proof of selective neuronal loss following status epilepticus appeared early in the 18th century, describing a sequence of cellular changes observed with Nissl staining in the brains of seven patients dying during the course of status epilepticus ([@B21]). The idea that ischemic processes could explain the cell loss in status epilepticus was developed about 100 years ago but questioned steadily based on the presence of massive hyperaemia and hyperoxygenation ([@B128]; [@B108]). Alternatively [@B132] suggested that not hypoxia but rather the release of endogenous substances and excitotoxic cascades mediate an excessive rise in \[Ca^2+^\]i resulting in cell death. Theoretically, a relative hypoperfusion of the tissue might occur also with intact neurovascular coupling if we presume that the diffusion-limited oxygen delivery can not keep up with a local increases in CMRO~2~. This kind of hypoperfusion might underlie the local negative BOLD signal indicating a mismatch between CBF and CMRO~2~ ([@B146]). While such changes would remain undetected with the conventional doppler flowmetry ([@B53]), doppler-based functional ultrasound imaging modality could reveal seizure-associated relative hypoperfusion at the microcircuitry level ([@B167]). Oxygen transport from the capillary in the tissue is driven by the oxygen gradient within the tissue. Thus an increase in CMRO~2~ would require an equal increase in the oxygen gradients. Taking into account that during high energy demand a significant part of the tissue exhibits pO~2~ below 50% compared to the capillary value ([@B144]), the increase in capillary pO~2~ observed as a positive BOLD signal can still mean hypoxic pO~2~ at certain places within the brain parenchim. Such phenomenon was observed during spreading depolarization in the neocortex where monitoring the tissue redox potential revealed hypoperfused "islets" between capillaries ([@B160]). Similar hypoperfused areas might be present at the immediate vicinity of seizure focus, indicating altered blood distribution rather than disturbances of neurovascular coupling ([@B177]). On the other hand, status epilepticus was shown to induce damage and to severely alter the neurovascular unit, including dysfunction of the blood-brain-barrier (BBB, [@B1]; [@B66]), which might also affect the functionality of neurovascular coupling and substrate supply during recurrent seizures. Thus interictal hypoperfusion is not a sole consequence of cell loss and impaired neuronal energy metabolism but it might also represent disturbances of neurovascular coupling at the microcirculation level (see next chapter).

Uncoupling of Blood Flow and Ictal Events and Postictal Disturbances of Metabolic Supply
========================================================================================

Neurovascular coupling necessitates information flow between neurons, astrocytes, endothelial cells and the contractile elements of the vasculature, i.e., the smooth muscle cells in arterioles and pericytes in capillaries ([@B127]; [@B60]). Disturbances in NVC has been associated with several pathologies, including stroke ([@B175]), hypertension ([@B30]), Alzheimer's disease ([@B135]), and subarachnoid hemorrhage ([@B131]). In epilepsy, alterations in the function of the neurovascular unit were found in epileptic tissue following status epilepticus leading to BBB impairment ([@B56]; [@B6]). Following pilocarpine-induced status epilepticus heterogeneously distributed vascular alterations were observed within the cerebral cortex ([@B34]). Superficial arteries and veins remained intact allowing for increased blood flow, whereas microvasculature showed a reduction of the diameter, resulting in an ischemic core in the deeper layers of the cortex. Moreover, neurovascular coupling was found to be deviate from the electrical activity and even impaired following seizures ([@B122], [@B123]; [@B105]; [@B62]), thus raising the question whether inadequate perfusion and hypoxia may contribute to the pathophysiological changes in energy metabolism following status epilepticus. Indeed, fluorescence life-time measurement of NADH revealed metabolic impairment in bicuculline induced focal seizure activity *in vivo* likely due to inadequate blood supply ([@B174]).

With respect to microcirculation, gap junction-coupled contractile pericytes gained importance as the key executors of neurovascular coupling at the capillaries ([@B126]; [@B60]; [@B111]). Pericytic injury has been described to be accompanied by neurovascular dysfunction in various neurological disorders(for review see [@B172]). Pericyte degeneration induced white-matter hypoxia and loss of myelin, ([@B114]) and peroxynitrite-dependent pericytic dysfunction could completely disrupt passage of erythrocytes in capillaries as seen in the no-reflow phenomenon following ischemia ([@B175]). On the other hand, [@B60] found free radical-independent pericytic dysfunction following oxygen glucose deprivation in brain slices. Similar to hypoxia-reperfusion, epileptic seizures are also associated with increased formation of oxygen and nitrogen centered free radicals, both *in vivo* ([@B46]) and *in vitro* ([@B91], [@B90]). However, it is not known whether the formation of free radicals during status epilepticus would also influence pericyte function. Nevertheless, the redistribution of pericytes have been shown after status epilepticus ([@B110]) and pericyte-mediated capillary vasospasm was observed in a genetic model of epilepsy and in kainic acid-treated animals following seizure onset ([@B97]). Postictal hypoxia due to cyclooxygenase-2 activity-dependent vasoconstriction has been made responsible for the debilitating consequences of seizures ([@B36], [@B35]). Theoretically, such changes in capillary perfusion would remain undetected with conventional methods of blood flow monitoring and could contribute to the development of local under-supply in case of subsequent seizures. Altogether, these studies highlight the importance of examining the time course and development of metabolic- and neurovascular-abnormalities associated with seizures. Besides the fact that capillaries are buried deep in the brain tissue and only accessible to multiphoton imaging or endomicroscopy, the difficulty with monitoring of pericytic regulation of capillary blood flow during seizures *in vivo* is that dilations of precapillary arteries/arterioles or changes in systemic blood pressure might influence the responses of pericytes ([@B39]). Alternatively, the use of *in vitro* preparation have been suggested that combine the application of haemodynamic variables (such as flow and pressure) into parenchymal arterioles with the advantages of capillary imaging in brain slices ([@B81]). In order to study capillary responses and BBB function in a controlled microenvironment we established a slice culture model of organotypic microvasculature. In this experimental setting, components of the neurovascular unit and BBB remain functional ([@B117]; [@B17]) and pericyte-derived contractile cells regulate capillary diameter in response to vasoactive substrates and increased intramural pressure ([@B89]). Moreover, vascular remodeling takes place upon lasting epileptiform activity, mimicking seizure-associated disturbances in neurovascular unit ([@B116]). Investigating capillary vasomotility in this preparation could provide insights on the mechanisms of pericytic disturbances underlying neurovascular uncoupling.

Concluding Remarks
==================

In conclusion, substantial evidence suggests that seizure termination can occur in the presence of intact neurometabolic coupling and overshooting neurovascular responses without immediate limitation on the metabolism. On the other hand, enhanced energy metabolism exerts a strong negative feedback on neuronal excitability, mostly via adenosine and pH changes. Free radical-dependent damage of mitochondrial enzymes and the subsequent disturbances in energy metabolism observed in chronic epileptic tissue were found to be rather proconvulsive (**Figure [2](#F2){ref-type="fig"}**). Manipulating substrate availability, preventing glycolysis, lactate uptake as well as enhancing pentose phosphate shunt might have both acute pro- or anticonvulsant effects, whereas chronic dietary changes can exert seizure control via epigenetic mechanisms. Thus targeting negative feedback mechanisms involved in metabolism dependent regulation of excitability as well as supporting cellular bioenergetics and protecting neurovascular coupling may represent promising therapeutic approaches in the treatment of epilepsy.
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